[EN] ACTIVATORS OF KLF14 AND USES THEREOF<br/>[FR] ACTIVATEURS DE KLF14 ET LEURS UTILISATIONS
申请人:UNIV MICHIGAN REGENTS
公开号:WO2017044607A1
公开(公告)日:2017-03-16
The present invention provides compositions enhancing reverse cholesterol transport through increasing HDL-C and ApoA-1 levels and enhancing cholesterol efflux, and related methods of treating and/or preventing cardiovascular disease (e.g., atherosclerosis, dyslipidemia, hypercholesterolemia and inflammation). In particular, the invention relates to compositions capable of increasing KLF14 activity for purposes of increasing levels and functions of HDL-C and ApoA-1 and cholesterol efflux in macrophage, and as a result, enhancing reverse cholesterol transport.